Rankings
▼
Calendar
MLTX Q1 2021 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena
MLTX
MoonLake Immunotherapeutics
$1B
Q1 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$94,106
Net Income
-$76,291
EPS (Diluted)
$-0.01
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$107,795
Free Cash Flow
-$107,795
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$116M
Total Liabilities
$4M
Stockholders' Equity
$112M
Cash & Equivalents
$1M
← FY 2021
All Quarters
Q2 2021 →
